Who are we?
The Cambridge Eye Trust was initiated in 1970 by a number of consultants in Cambridge who believed that they had an opportunity to improve eye care through:
Specific financial support of the Professor of Ophthalmology at Cambridge University by providing departmental grants
Funding non-commercial ophthalmic research programmes without the need to rely on other sources, expediting discovery
Giving doctors from worldwide destinations (through the Cambridge Ophthalmological Symposium) an opportunity to learn from, and discuss medical innovation with, those at the peak of their research or clinical field.
The Cambridge Eye Trust has always, and always will, rely on pledges and donations from the public. We thank those who have contributed over the years to ensuring we move towards our goal - to save sight.
What next? The Trust retains its pledge made over 40 years ago to East Anglia and the UK to support ophthalmology good works.
Why support us?
We hope that you are visiting our website because you are interested in improving eye care, for you, your family or for future generations. Perhaps you want to find out more about what we do or are considering making a donation or pledge to a charity like ours?
We are a small charity, we do not have corporate sponsors or a famous name associated with us and therefore less than 0.001% of our moneys are spent on charity administration. We rely on our knowledgeable, esteemed Trustee membership to review and approve projects, ensuring the Cambridge Eye Trust 'makes things happen'.
Why consider supporting eye care?
It would not be an understatement to say that having sight is one of most important senses a person has. That the loss of sight can have a real detrimental impact on that person and their family. While failing sight does comes with age, there are millions of children and adults who are affected early by poor sight or blindness because their condition is picked up too late, the cause of the condition is not known about or a successful treatment is not available. Our fundamental aim, in some small way is to be a catalyst for ophthalmic treatment progression.